<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><title>Access Board Working Group on Accessible Drug Labels to Hold Teleconferences</title><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.style3, li.style3, div.style3
{mso-style-name:style3;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:navy;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:blue;
font-weight:bold;
font-style:normal;
text-decoration:none none;}
span.style5
{mso-style-name:style5;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle26
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.25in 1.0in 1.25in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=blue><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Sigman, Brian [mailto:Brian.Sigman@ct.gov] <br><b>Sent:</b> Friday, April 05, 2013 1:59 PM<br><b>To:</b> BESB-DL All Users; Sylvestre, Alan; 'brucewoodie@msn.com'; 'chrisb274@gmail.com'; 'e.g.akers@sbcglobal.net'; 'mcdodd3020@sbcglobal.net'; 'johnsonp@ciboakhill.org'; 'bdemaio@newbritainct.gov'; 'randa.utter@cga.ct.gov'; 'gillispiegeorge@sbcglobal.net'; 'ckuell@comcast.net'; 'fairbanks@ldeo.columbia.edu'; 'iancr@comcast.net'; 'llee@nfbct.org'; 'sbaecker@snet.net'; 'jaykronfeld@sbcglobal.net'; 'famigliettis@ciboakhill.org'; 'info@nfbct.org'; 'pacvi2@aol.com'; 'erival@comcast.net'; 'carolyn.messier@aol.com'; 'optometric.assoc01@snet.net'; 'Eyecare@inclima.net'; 'epinnod@aol.com'; 'Dr.george.adrian@snet.net'; 'Westendeyecare@snet.net'; 'ks@drkimstevens.com'; 'Rkinkade@optonline.net'; 'rstrand@eyecarect.com'; 'optometric.assoc01@snet.net'; 'Drswsm@yahoo.com'; 'bboogie@snet.net'; 'davidparke@comcast.net'; 'larrykline@bigplanet.com'; Filippone, Jennifer; 'enfield-eyecare@cox.net'; 'mgenlot@snet.net'; 'r.h.tyler@sbcglobal.net'; 'lighthouse63@gmail.com'; White, Dee A.; Gerundo-Murkette, Margaret A.; 'ks@drkimstevens.com'; Mawson, Stacie J; 'maryellen.barbiasz@hknc.org'; Blewett, Kathleen K.; 'rjcloonan@comcast.net'; 'waltersd@ciboakhill.org'; 'Sandy.Inzinga@asd-1817.org'; Morgan, Siobhan C; 'jbperacchio@gmail.com'; Thal, Stephen; 'funnytomkaren@gmail.com'; 'dawgmawm@gmail.com'; 'charlie@visiondynamics.com'; Cunnane, Brian; Dombrowski, Stephen; 'c.rafala@snet.net'; 'clow@independenceunlimited.org'; 'sbaecker@crisradio.org'; 'jbperacchio@gmail.com'; 'dgregoire@liberty-bank.com'; 'judith.tencza@med.va.gov'; 'stovallb@ciboakhill.org'; '5040psbs@cox.net'; 'c.ford3@sbcglobal.net'; 'alfredthompsonjr@yahoo.com'; 'davescoffee@juno.com'; Reitano, Andrew; 'lewis_andrews@sbcglobal.net'; 'mvlagocki@aol.com'; 'dave.figley@snet.net'; 'famigliettis@ciboakhill.org'; 'ajackson212@att.net'; 'junerose@startsimply.com'; 'eileen.healy@independencenorthwest.org'; 'tlacava@drcfc.org'; 'marcanthony@cdr-ct.org'; 'ferrycathy@yahoo.com'; 'magallucci@aol.com'; 'momforch@yahoo.com'; 'slkush93@att.net'; 'cheleot@comcast.net'; 'Rachriste1@cs.com'; 'diana200561@yahoo.com'; 'f_roberts@comcast.net'; 'joenerney@charter.net'; 'Raymo@Intergate.com'; Mandry, Marisel; 'marysilverfox@gmail.com'; 'Rb8876@aol.com'; 'khaley18@comcast.net'; 'pvlandis@ncc.commnet.edu'; 'Barbara.blejewski@sbcglobal.net'; 'dwdunne@crisradio.org'; Miles, Sandra; 'connecticutcounciloftheblind@gmail.com'; 'lbphtom@gmail.com'; 'futureeyecare2020@gmail.com'; Friedman, Sharon; 'nyemapinkney@comcast.net'; 'carlnoll@sbcglobal.net'; 'AlbanB@aol.com'; 'emtelk@earthlink.net'; 'diannmurray1@gmail.com'; 'emmbee4@yahoo.com'; 'e.email@snet.net'; 'daria@ctsilc.org'; 'centeroftheblind@sbcglobal.net'; Reddick, Gordon; 'bob.gorman@independencenorthwest.org'<br><b>Subject:</b> FW: [Cclvi-announce] Access Board Working Group on Accessible DrugLabels to Hold Teleconferences<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><div><p class=MsoNormal><b><span style='font-size:16.0pt;font-family:"Arial","sans-serif"'>From: <a href="mailto:cclvi-announce-bounces@cclvi.org">cclvi-announce-bounces@cclvi.org</a> [<a href="mailto:cclvi-announce-bounces@cclvi.org">mailto:cclvi-announce-bounces@cclvi.org</a>] On Behalf Of CCLVI announce<br>Sent: Thursday, April 04, 2013 5:52 PM<br>To: CCLVI-announce; CCLVI-l; CCLVI-Board; cclvi-leadership<br>Subject: [Cclvi-announce] Access Board Working Group on Accessible DrugLabels to Hold Teleconferences<o:p></o:p></span></b></p></div><p class=MsoNormal><b><span style='font-size:16.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></b></p><div><div><div><p class=MsoNormal><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>Please mark your calendars for the below 2 meetings and join via the public comment portion if you are able.<o:p></o:p></span></b></p></div><div><p class=MsoNormal><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>Annette<o:p></o:p></span></b></p></div><div><div><div><p class=MsoNormal><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'> <o:p></o:p></span></b></p></div></div></div><div><p><strong><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>Access Board Working Group on Accessible Drug Labels to Hold Teleconferences </span></strong><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'><o:p></o:p></span></b></p><p><span class=style5><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>A working group organized by the Access Board to develop best practices for making drug labels accessible to people who are visually impaired or who are elderly will convene by teleconference on </span></b></span><strong><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>April 9</span></strong><span class=style5><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'> and </span></b></span><strong><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>April 22</span></strong><span class=style5><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'> from </span></b></span><strong><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>1:00 to 5:00 (ET)</span></strong><span class=style5><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>. The meetings will focus on discussion of revisions to the working group’s draft report to the Board. Members of the public can follow the proceedings through the toll-free conference line or online real-time transcription. </span></b></span><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'><o:p></o:p></span></b></p><p><span class=style5><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>For further information, visit the Board’s <a href="http://links.govdelivery.com:80/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTMwMzI1LjE3MDQ3OTExJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDEzMDMyNS4xNzA0NzkxMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE3NDcwODE3JmVtYWlsaWQ9YW5uZXR0ZS5jYXJ0ZXJAcGFjYmVsbC5uZXQmdXNlcmlkPWFubmV0dGUuY2FydGVyQHBhY2JlbGwubmV0JmZsPSZleHRyYT1NdWx0aXZhcmlhdGVJZD0mJiY=&&&100&&&http://www.access-board.gov/drug-labels/index.htm">website</a> or contact Susan Crawford at <a href="mailto:crawford@access-board.gov">crawford@access-board.gov</a>, (202) 272-0029 (v), or (202) 272-0082 (TTY).</span></b></span><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'><o:p></o:p></span></b></p><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p><em><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>Teleconferences of the Accessible Prescription Drug Labels Working Group </span></b></em><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'><br><span class=style5>April 9, 1:00 - 5:00 (ET)</span><br><span class=style5>April 22, 1:00 - 5:00 (ET)</span><br><span class=style5>Dial: (888) 603-7094 </span><br><span class=style5>Passcode: 6317703</span><o:p></o:p></span></b></p><p class=style3><em><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'>Real-time transcription:</span></b></em><b><span lang=EN style='font-size:16.0pt;font-family:"Arial","sans-serif";color:black'> <br>[The link will be posted on the Board's <a href="http://links.govdelivery.com:80/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTMwMzI1LjE3MDQ3OTExJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDEzMDMyNS4xNzA0NzkxMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE3NDcwODE3JmVtYWlsaWQ9YW5uZXR0ZS5jYXJ0ZXJAcGFjYmVsbC5uZXQmdXNlcmlkPWFubmV0dGUuY2FydGVyQHBhY2JlbGwubmV0JmZsPSZleHRyYT1NdWx0aXZhcmlhdGVJZD0mJiY=&&&100&&&http://www.access-board.gov/drug-labels/index.htm">website</a>.]<o:p></o:p></span></b></p></blockquote></div></div></div></div></body></html>